Surrey researchers Sign in
HXR9 AND PARP INHIBITION -A NOVEL THERAPEUTIC IN OVARIAN CANCER
Conference presentation   Peer reviewed

HXR9 AND PARP INHIBITION -A NOVEL THERAPEUTIC IN OVARIAN CANCER

Z Kelly, H Pandha, R Morgan and A Michael
ANNALS OF ONCOLOGY, Vol.23, pp.325-325
37th Congress of the European-Society-for-Medical-Oncology (ESMO) (Vienna, AUSTRIA, 28/09/2012 - 02/10/2012)
01/09/2012

Abstract

Science & Technology Life Sciences & Biomedicine Oncology ONCOLOGY
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000309409001468&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

29 Record Views

Details

Usage Policy